NMS Group
Alessia Burocchi is a scientist at NMS Group - Nerviano Medical Sciences since March 2017, following a significant academic and research career in the field of tumor immunology. Prior to this role, Alessia served as a postdoctoral researcher and PhD student at the IRCCS Istituto Nazionale dei Tumori Foundation in Milan, Italy, focusing on molecular immunology. Earlier experience includes a research fellowship at Ospedale San Raffaele in the lab of Immunohistochemistry and Molecular Biology. Alessia holds a Master in Medical Management from ISTUM and a PhD in Tumor Immunology from The Open University, along with advanced degrees in Medical Biotechnologies from Libera Università Vita-Salute San Raffaele and Università degli Studi di Milano.
This person is not in the org chart
This person is not in any offices
NMS Group
NMS Group S.p.A. is the largest company in Italy committed in innovation and oncology R&D. With 420 total employees, NMS Group employs over 200 qualified researchers involved in research and development, from 'target validation' to phase II clinical trials. NMS Group S.p.A. is the only company in Italy able to manage the entire integrated chain of the research and development path: from pre-clinical phase of research, to First-Time-In-Man of clinical phase, up to production and packaging of the finished drug. The Group also provides services of Research and Production addressed to local and international markets through three different companies: Accelera, one of the few companies engaged in preclinical research in Italy; Clioss engaged in clinical development starting from First-Time-In-Man and Nerpharma, dealing with activities from formulation to production of the active principle.